Roth Capital raised the firm's price target on Bowman Consulting to $58 from $50 and keeps a Buy rating on the shares after its Q1 results. The firm is positive on the company's robust organic growth profile that carries at least through 2027, also stating that the high degree of visibility, robust backlog and strong demand across Bowman segments provide a convincing foundation for attractive growth over at least the next two years, the analyst tells investors in a research note.